152 related articles for article (PubMed ID: 21454040)
1. Vasopressor administration and sepsis: a survey of Canadian intensivists.
Lamontagne F; Cook DJ; Adhikari NKJ; Briel M; Duffett M; Kho ME; Burns KEA; Guyatt G; Turgeon AF; Zhou Q; Meade MO
J Crit Care; 2011 Oct; 26(5):532.e1-532.e7. PubMed ID: 21454040
[TBL] [Abstract][Full Text] [Related]
2. A survey of Canadian intensivists' resuscitation practices in early septic shock.
McIntyre LA; Hébert PC; Fergusson D; Cook DJ; Aziz A;
Crit Care; 2007; 11(4):R74. PubMed ID: 17623059
[TBL] [Abstract][Full Text] [Related]
3. Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS).
Jeon K; Song JU; Chung CR; Yang JH; Suh GY
Crit Care; 2018 May; 22(1):131. PubMed ID: 29784057
[TBL] [Abstract][Full Text] [Related]
4. Practice Patterns and Outcomes Associated With Choice of Initial Vasopressor Therapy for Septic Shock.
Fawzy A; Evans SR; Walkey AJ
Crit Care Med; 2015 Oct; 43(10):2141-6. PubMed ID: 26079345
[TBL] [Abstract][Full Text] [Related]
5. Vasopressor weaning in patients with septic shock.
Arellano DL; Hanneman SK
Crit Care Nurs Clin North Am; 2014 Sep; 26(3):413-25. PubMed ID: 25169693
[TBL] [Abstract][Full Text] [Related]
6. Multi-complexity measures of heart rate variability and the effect of vasopressor titration: a prospective cohort study of patients with septic shock.
Brown SM; Sorensen J; Lanspa MJ; Rondina MT; Grissom CK; Shahul S; Mathews VJ
BMC Infect Dis; 2016 Oct; 16(1):551. PubMed ID: 27724850
[TBL] [Abstract][Full Text] [Related]
7. A time-sensitive analysis of the prognostic utility of vasopressor dose in septic shock.
Chotalia M; Matthews T; Arunkumar S; Bangash MN; Parekh D; Patel JM
Anaesthesia; 2021 Oct; 76(10):1358-1366. PubMed ID: 33687732
[TBL] [Abstract][Full Text] [Related]
8. Delayed vasopressor initiation is associated with increased mortality in patients with septic shock.
Colon Hidalgo D; Patel J; Masic D; Park D; Rech MA
J Crit Care; 2020 Feb; 55():145-148. PubMed ID: 31731173
[TBL] [Abstract][Full Text] [Related]
9. Corticosteroid use in the intensive care unit: a survey of intensivists.
Lamontagne F; Quiroz Martinez H; Adhikari NK; Cook DJ; Koo KK; Lauzier F; Turgeon AF; Kho ME; Burns KE; Chant C; Fowler R; Douglas I; Poulin Y; Choong K; Ferguson ND; Meade MO
Can J Anaesth; 2013 Jul; 60(7):652-9. PubMed ID: 23606231
[TBL] [Abstract][Full Text] [Related]
10. Vasopressor dosing in septic shock.
Alaniz C; Pollard S
Crit Care Med; 2013 Dec; 41(12):e483-4. PubMed ID: 24275412
[No Abstract] [Full Text] [Related]
11. Evaluation of Practice Changes in the Care of Patients with Septic Shock during the U.S. Norepinephrine Shortage.
Wunsch H; Hua M; Walkey AJ; Rubenfeld G; Vail E; Gershengorn HB
Ann Am Thorac Soc; 2018 Apr; 15(4):509-511. PubMed ID: 29537858
[No Abstract] [Full Text] [Related]
12. Association of Premorbid Blood Pressure with Vasopressor Infusion Duration in Patients with Shock.
Gershengorn HB; Stelfox HT; Niven DJ; Wunsch H
Am J Respir Crit Care Med; 2020 Jul; 202(1):91-99. PubMed ID: 32272020
[No Abstract] [Full Text] [Related]
13. Survey of vasopressor usage.
Wolfe T; Dasta J; Reilley T; Flancbaum L
Intensive Care Med; 1998 Aug; 24(8):890. PubMed ID: 9757938
[No Abstract] [Full Text] [Related]
14. Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock?
Carr AC; Shaw GM; Fowler AA; Natarajan R
Crit Care; 2015 Nov; 19():418. PubMed ID: 26612352
[TBL] [Abstract][Full Text] [Related]
15. Prescribing patterns of hydrocortisone in septic shock: a single-center experience of how surviving sepsis guidelines are interpreted and translated into bedside practice.
Contrael KM; Killian AJ; Gregg SR; Buchman TG; Coopersmith CM
Crit Care Med; 2013 Oct; 41(10):2310-7. PubMed ID: 23787398
[TBL] [Abstract][Full Text] [Related]
16. Vasopressors and Inotropes in Sepsis.
Stratton L; Berlin DA; Arbo JE
Emerg Med Clin North Am; 2017 Feb; 35(1):75-91. PubMed ID: 27908339
[TBL] [Abstract][Full Text] [Related]
17. Intensity of Vasopressor Therapy for Septic Shock and the Risk of In-Hospital Death.
Brand DA; Patrick PA; Berger JT; Ibrahim M; Matela A; Upadhyay S; Spiegler P
J Pain Symptom Manage; 2017 May; 53(5):938-943. PubMed ID: 28062334
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II: a new approach for refractory shock management?
Kimmoun A; Levy B
Crit Care; 2014 Dec; 18(6):694. PubMed ID: 25645552
[TBL] [Abstract][Full Text] [Related]
19. CT-proAVP IS NOT A GOOD PREDICTOR OF VASOPRESSOR NEED IN SEPTIC SHOCK.
Laribi S; Lienart D; Castanares-Zapatero D; Collienne C; Wittebole X; Laterre PF
Shock; 2015 Oct; 44(4):330-5. PubMed ID: 26196839
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.
Patel GP; Grahe JS; Sperry M; Singla S; Elpern E; Lateef O; Balk RA
Shock; 2010 Apr; 33(4):375-80. PubMed ID: 19851126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
